The Geneva-based startup just announced the completion of its Series B financing round, raising in total CHF 33.2 million.

Read Venturelab's interview of AMAL Therapeutics' CEO and Founder, Madiha Derouazi

Link to interview

Find an actor

BioAlps World Visibitlity Package 201918.03.2019

A yearly international programme for our affiliated companies to increase their visibility.

BioAlps World Visibitlity Package 2019

A yearly international programme for our affiliated companies to increase their visibility.
Print this page Download this page (PDF) Recommend this page to a friend

Contact us

BioAlps Association
Ch. du Pré-Fleuri 3
CH - 1228 Plan-les Ouates
+41 22 304 40 40
+41 22 304 40 70

Subscribe to our newsletter

Find us on LinkedIn